Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: April 2008
-
By Christopher P. Singer — In a recent notice, the U.S. Patent and Trademark Office announced that it has launched the "Financial Profile" (FP) system which allows users to access payment history through a secure (and fast) website. Users of the FP are able to view detailed information for all fees paid to…
-
By Kevin E. Noonan — Gina Kolata identifies the villain of her recent piece in The New York Times on rising drug costs in the first sentence: "[h]ealth insurance companies" that have changed their reimbursement and prescription drug coverage for certain high-priced drugs (see "Co-Payments Soar for Drugs With High Prices"). But that…
-
By Christopher P. Singer — In an April 7, 2008 press release, the U.S. Patent and Trademark Office announced a new two year pilot program that will allow a limited number of law students to practice before the Patent Office. The program will include opportunities in both patent and trademark branches of the…
-
By Robert Dailey — Innogenetics and Abbott have agreed to settle their dispute over Innogenetics’ patented methods for genotyping HCV. Abbott will shell out $9.5 million, including on-going royalty payments for each test sold by Abbott. We have previously discussed developments in the litigation between Innogenetics and Abbott over U.S. Patent 5,846,704 (see…
-
By Donald Zuhn — On Monday, the U.S. Patent and Trademark Office announced that it will be initiating a new pilot program that is expected to reduce application pendency and improve patent quality. The First Action Interview pilot program, which will begin on April 28th and run for six months, will allow applicants…
-
By Kevin E. Noonan — Before Hoffmann-LaRoche filed its Notice of Appeal in the Court of Appeals for the Federal Circuit last week, appealing the preliminary injunction Judge William Young entered that prevents Roche from selling its Mircera® drug product (a form of recombinant EPO that has been covalently linked to polyethylene glycol),…
-
The Law Journal of Technology & Intellectual Property at the Northwestern University School of Law will be holding its Third Annual Symposium on April 18, 2008 in Chicago, IL. The Symposium, entitled "Following the Yellow Brick Road: The Future of Intellectual Property," will consist of the following sessions: • IP Litigation in the 21st Century…
-
By Kevin E. Noonan — Perhaps surprisingly, the Biotechnology Industry Organization (BIO) filed an amicus brief last week in In re Bilski, a case under en banc consideration by the Federal Circuit over a Patent Office determination that the claimed subject matter (a method of managing the risk of bad weather through commodities…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Ortho-McNeil Pharmaceutical, Inc. v. Mylan Pharmaceuticals, Inc. et al.1:08-cv-00101; filed April 9, 2008 in the Northern District of West Virginia Infringement of…
-
April 25, 2008 – Patent Claim Construction (Law Seminars International) – Atlanta, GA April 30, 2008 – Public PAIR and Data-Mining Requests Webcast (U.S. Patent and Trademark Office) April 30-May 1, 2008 – Pharma/Biotech Collaborative Agreements (American Conference Institute) – San Francisco, CA May 15, 2008 – The Federal Circuit: A National Court of Appeals:…
Patent Docs 